Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program

Selection by both the NIA ITP and ARPA-H PROSPR programs highlights growing recognition of LNS8801’s potential to promote ...
Business Wire

SecurAcath Selected for Fast-Track NHS Use Through New Innovation and Technology Payment Program

PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Catheter Securement Device has been selected for the Innovation and ...
Nasdaq

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

The potential contract value if the three-year extension option is exercised could be up to approximately £3.6 million (or approximately $4.6 million based on the current exchange rate) “The extension ...
Business Insider

electroCore Selected for Innovation and Technology Payment Program Through NHS England

LONDON and BASKING RIDGE, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore, ...
Business Insider

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in the U.K.

BASKING RIDGE, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that England’s National Health Service (NHS ...